🇺🇸 FDA
Pipeline program

Beclomethasone dipropionate

BDP-AR-303

Phase 3 small_molecule completed

Quick answer

Beclomethasone dipropionate for Rhinitis, Allergic, Perennial is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Rhinitis, Allergic, Perennial
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials